FY2025 EPS Estimates for Societal CDMO, Inc. Boosted by Analyst (NASDAQ:SCTL)

Societal CDMO, Inc. (NASDAQ:SCTLGet Rating) – Equities researchers at William Blair increased their FY2025 earnings per share estimates for shares of Societal CDMO in a research note issued to investors on Thursday, May 12th. William Blair analyst J. Kreger now forecasts that the company will post earnings per share of $0.07 for the year, up from their prior estimate of $0.03.

Separately, Zacks Investment Research upgraded shares of Societal CDMO from a “hold” rating to a “buy” rating and set a $2.00 price objective for the company in a research report on Wednesday, April 6th.

Societal CDMO stock traded down $0.23 during midday trading on Friday, hitting $1.00. 200,225 shares of the stock were exchanged, compared to its average volume of 106,943. Societal CDMO has a fifty-two week low of $0.88 and a fifty-two week high of $2.67. The company has a debt-to-equity ratio of 2.27, a quick ratio of 2.74 and a current ratio of 3.24.

Societal CDMO (NASDAQ:SCTLGet Rating) last released its quarterly earnings data on Wednesday, May 11th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.01. Societal CDMO had a negative net margin of 15.15% and a negative return on equity of 56.66%.

Societal CDMO Company Profile (Get Rating)

Societal CDMO, Inc, a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services.

Featured Stories

Receive News & Ratings for Societal CDMO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Societal CDMO and related companies with MarketBeat.com's FREE daily email newsletter.